全文获取类型
收费全文 | 1333088篇 |
免费 | 102432篇 |
国内免费 | 4234篇 |
专业分类
耳鼻咽喉 | 16865篇 |
儿科学 | 43703篇 |
妇产科学 | 36475篇 |
基础医学 | 197622篇 |
口腔科学 | 36038篇 |
临床医学 | 129538篇 |
内科学 | 257264篇 |
皮肤病学 | 26401篇 |
神经病学 | 111971篇 |
特种医学 | 48261篇 |
外国民族医学 | 366篇 |
外科学 | 184271篇 |
综合类 | 28884篇 |
现状与发展 | 1篇 |
一般理论 | 465篇 |
预防医学 | 114224篇 |
眼科学 | 28976篇 |
药学 | 99117篇 |
6篇 | |
中国医学 | 3151篇 |
肿瘤学 | 76155篇 |
出版年
2021年 | 10731篇 |
2019年 | 11716篇 |
2018年 | 16380篇 |
2017年 | 12376篇 |
2016年 | 13322篇 |
2015年 | 15275篇 |
2014年 | 20913篇 |
2013年 | 32209篇 |
2012年 | 44498篇 |
2011年 | 47180篇 |
2010年 | 27220篇 |
2009年 | 25066篇 |
2008年 | 42953篇 |
2007年 | 45284篇 |
2006年 | 45389篇 |
2005年 | 43801篇 |
2004年 | 41814篇 |
2003年 | 39703篇 |
2002年 | 38484篇 |
2001年 | 60980篇 |
2000年 | 62666篇 |
1999年 | 52410篇 |
1998年 | 14642篇 |
1997年 | 13275篇 |
1996年 | 12213篇 |
1995年 | 12404篇 |
1994年 | 11620篇 |
1993年 | 10870篇 |
1992年 | 41584篇 |
1991年 | 40825篇 |
1990年 | 39556篇 |
1989年 | 37403篇 |
1988年 | 34613篇 |
1987年 | 33754篇 |
1986年 | 32192篇 |
1985年 | 30713篇 |
1984年 | 23070篇 |
1983年 | 19605篇 |
1982年 | 11719篇 |
1979年 | 20815篇 |
1978年 | 14798篇 |
1977年 | 12048篇 |
1976年 | 11872篇 |
1975年 | 12102篇 |
1974年 | 14824篇 |
1973年 | 14486篇 |
1972年 | 13387篇 |
1971年 | 12431篇 |
1970年 | 11498篇 |
1969年 | 10431篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
D. Baker G. Pryce L. K. James K. Schmierer G. Giovannoni 《European journal of neurology》2020,27(2):221-228
Clinical trials are probably the most informative experiments to help an understanding of multiple sclerosis (MS) biology. Recent successes with CD20‐depleting antibodies have focused attention towards B cell subsets as important mediators in MS. The trial of tabalumab (NTC00882999), which inhibits B cell activation factor (BAFF), is reported and reviewed and this trial is contrasted with the trial on the inhibition of a proliferation‐inducing ligand (APRIL) and BAFF using atacicept (NCT00642902). Both tabalumab and atacicept induce depletion of mature B cells and inhibit antibody formation, but they fail to deplete memory B cells and do not inhibit relapsing MS. Atacicept is reported to augment memory B cell responses and may precipitate relapse, suggesting the importance of APRIL. However, BAFF inhibition can enhance peripheral blood memory B cell responses, which was not associated with augmented relapse. Although other interpretations are possible, these data further support the hypothesis that memory B cells may be of central importance in relapsing MS, as they are the major CD20+ B cell subset expressing APRIL receptors. They also suggest that quantitative and/or qualitative differences in B cell responses or other factors, such as an immune‐regulatory effect associated with APRIL, may be important in determining whether MS reactivates following neutralization of peripheral B cell maturation and survival factors. 相似文献
74.
75.
Magon Stefano Pfister Armanda Laura Gaetano Lüthi Martin Papadopoulou Athina Kappos Ludwig Sprenger Till 《Brain imaging and behavior》2020,14(6):2159-2175
Brain Imaging and Behavior - Motor learning is a multi-stage process, in which the involvement of different brain regions is related to the specific stage. We aimed at characterising short... 相似文献
76.
Nevo N. Goldstein A. L. Staierman M. Eran N. Carmeli I. Rayman S. mnouskin Y. 《Hernia》2022,26(6):1491-1499
Hernia - The minimally invasive surgical repair of combined inguinal and ventral hernias often requires shifting from one approach or plane to another. The traditional enhanced-view totally... 相似文献
77.
78.
79.
Anuj Shrestha Zeeshan Jawa Kathryn L. Koch Amy B. Rankin Qun Xiang Anand Padmanabhan Matthew S. Karafin Joshua J. Field 《Journal of clinical apheresis》2015,30(6):353-358
Red cell exchange (RCE) is a common procedure in adults with sickle cell disease (SCD). Implantable dual lumen Vortex (DLV) ports can be used for RCE in patients with poor peripheral venous access. We performed a retrospective cohort study of RCE procedures performed in adults with SCD. The main objective of the study was to compare the inlet speed, duration of procedures and rate of complications performed through DLV ports to those performed through temporary central venous and peripheral catheters. Twenty‐nine adults with SCD underwent a total of 318 RCE procedures. Twenty adults had DLV ports placed and 218 procedures were performed using DLV ports. Mean length of follow‐up after DLV port placement was 397 ± 263 days. Six DLV ports were removed due to infection and 1 for malfunction after a mean of 171 ± 120 days. Compared to temporary central venous and peripheral catheters, DLV port procedures had a greater rate of procedural complications, a longer duration, and a lower inlet speed (all P < 0.01). When accounting for the maximum allowable inlet speed to avoid citrate toxicity, 40% of DLV port procedures were greater than 10% below maximum speed, compared to 7 and 14% of procedures performed through temporary central venous and peripheral catheters (P < 0.0001). In conclusion, DLV ports can be used for RCE in adults with SCD, albeit with more procedural complications and longer duration. The smaller internal diameter and longer catheter of DLV ports compared to temporary central venous catheters likely accounts for the differences noted. J. Clin. Apheresis 30:353–358, 2015. © 2015 Wiley Periodicals, Inc. 相似文献